Ditzingen, Germany

Ulrike Hahn

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.1

ph-index = 1


Location History:

  • Ditzingen, DE (2017)
  • Ditzingen-Heimerdingen, DE (2022)

Company Filing History:


Years Active: 2017-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ulrike Hahn: Innovator in Anti-Inflammatory and Anti-Cancer Compounds

Introduction

Ulrike Hahn is a prominent inventor based in Ditzingen, Germany. She has made significant contributions to the fields of anti-infective and anti-inflammatory compounds, as well as cancer treatment methodologies. With a total of 2 patents, her work is paving the way for innovative therapeutic solutions.

Latest Patents

Hahn's latest patents include groundbreaking research on anti-infective and anti-inflammatory compounds. These compounds consist of lysosomally accumulated substances that release a nitroxy group, short-chain fatty acids, or products of anaerobic metabolism. They exhibit anti-inflammatory, anti-cancer, and anti-bacterial activity, proving useful in treating infectious, inflammatory, and malignant diseases. Additionally, she has developed kinase modulators for cancer treatment. This method involves combining a compound that inhibits IL-10 expression with another that stimulates IL-12 production, enhancing the effectiveness of standard therapies, including chemotherapy and immune therapy.

Career Highlights

Ulrike Hahn is currently associated with Synovo GmbH, where she continues her research and development efforts. Her innovative approaches have garnered attention in the scientific community, contributing to advancements in medical treatments.

Collaborations

Hahn collaborates with esteemed colleagues, including Michael W. Burnet and Jan-Hinrich Guse. Their combined expertise fosters a dynamic research environment that enhances the potential for groundbreaking discoveries.

Conclusion

Ulrike Hahn's contributions to the fields of anti-inflammatory and anti-cancer research are noteworthy. Her innovative patents and collaborative efforts position her as a leading figure in the development of new therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…